Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification

Molecular Imaging

Volumn 7, Issue 4, 2008, Pages 175-186

  Liu, Fangbing ^a   Bloch, Nathalie ^a   Bhushan, Kumar R ^a   De Grand, Alec M ^a   Tanaka, Eiichi ^a   Solazzo, Stephanie ^a   Mertyna, Pawel M ^a   Goldberg, Nahum ^a   Frangioni, John V ^a   Lenkinski, Robert E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMINERALIZATION; BONE; CELL CULTURE; COMPUTERIZED TOMOGRAPHY; DISEASES; PROTEINS; TUMORS;

BONE MORPHOGENETIC PROTEIN-2; DIAGNOSTIC AGENTS; DIAGNOSTIC MARKERS; ENZYME LINKED IMMUNOSORBENT ASSAY; LIVING ANIMALS; MICROCALCIFICATIONS; MICROCOMPUTED TOMOGRAPHY; NEAR-INFRARED FLUORESCENCE;

DIAGNOSIS;

BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN, AEQUOREA VICTORIA;

ADENOCARCINOMA; ADENOVIRUS; ANIMAL; ARTICLE; BLOOD; BREAST; CALCINOSIS; EXPERIMENTAL NEOPLASM; FISCHER 344 RAT; GENETIC TRANSDUCTION; GENETICS; HUMAN; ISOGRAFT; METABOLISM; NEAR INFRARED SPECTROSCOPY; PATHOLOGY; RAT; SPECTROFLUOROMETRY; TOMOGRAPHY; TUMOR CELL CULTURE;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BREAST; CALCINOSIS; GREEN FLUORESCENT PROTEINS; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344; SPECTROMETRY, FLUORESCENCE; SPECTROSCOPY, NEAR-INFRARED; TOMOGRAPHY; TRANSDUCTION, GENETIC; TRANSPLANTATION, ISOGENEIC; TUMOR CELLS, CULTURED;

EID: 61949213192     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. American Cancer Society. Cancer facts and figures. Available at: http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf. (accesssed March 27, 2008)
2. van Ongeval C, Bosmans H, van Steen A. Current status of digital mammography for screening and diagnosis of breast cancer. Curr Opin Oncol 2006;18:547-54.
3. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA 2005;293:1245-56.
4. Morgan MP, Cooke MM, McCarthy GM. Microcalcifications associated with breast cancer: an epiphenomenon or biologically significant feature of selected tumors? J Mammary Gland Biol Neoplasia 2005;10:181-7.
5. Stomper PC, Geradts J, Edge SB, Levine EG. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass. AJR Am J Roentgenol 2003;181:1679-84.
6. Haka AS, Shafer-Peltier KE, Fitzmaurice M, et al. Identifying microcalcifications in benign and malignant breast lesions by probing differences in their chemical composition using Raman spectroscopy. Cancer Res 2002;62:5375-80.
7. Morgan MP, Cooke MM, Christopherson PA, et al. Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines. Mol Carcinog 2001;32:111-7.
8. Cooke MM, McCarthy GM, Sallis JD, Morgan MP. Phosphocitrate inhibits calcium hydroxyapatite induced mitogenesis and upregulation of matrix metalloproteinase-1, interleukin-lbeta and cyclooxygenase-2 mRNA in human breast cancer cell lines. Breast Cancer Res Treat 2003;79:253-63.
9. Kim JB, O'Hare MJ, Stein R. Models of breast cancer: is merging human and animal models the future? Breast Cancer Res 2004;6:22-30.
10. Pasini B, Casalis Cavalchini GC, Genovese T, Manoukian S. Evaluating breast cancer risk: available models to assess individual breast cancer risk and probability to be a BRCA mutation carrier. J Exp Clin Cancer Res 2002;21:23-9.
11. Tsukamoto AS, Grosschedl R, Guzman RC, et al. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988;55:619-25.
12. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004;23:1111-30.
13. Urist MR, Sato K, Brownell AG, et al. Human bone morphogenetic protein (hBMP). Proc Soc Exp Biol Med 1983;173:194-9.
14. Wang EA, Rosen V, Cordes P, et al. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci U S A 1988;85:9484-8.
15. Vainio S, Karavanova I, Jowett A, Thesleff I. Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development. Cell 1993;75:45-58.
16. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988;242:1528-34.
17. Yamaguchi A, Katagiri T, Ikeda T, et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991;113:681-7.
18. Li JZ, Li H, Sasaki T, et al. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther 2003;10:1735-43.
19. Kang Q, Sun MH, Cheng H, et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004;11:1312-20.
20. Feeley BT, Conduah AH, Sugiyama O, et al. In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models. J Orthop Res 2006;24:1709-21.
21. Helm GA, Sheehan JM, Sheehan JP, et al. Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion. J Neurosurg 1997;86:93-100.
22. Olmsted-Davis EA, Gugala Z, Gannon FH, et al. Use of a chimeric adenovirus vector enhances BMP2 production and bone formation. Hum Gene Ther 2002;13:1337-47.
23. Varady P, Li JZ, Alden TD, et al. CT and radionuclide study of BMP-2 gene therapy-induced bone formation. Acad Radiol 2002;9:632-7.
24. Clement JH, Raida M, Sanger J, et al. Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Int J Oncol 2005;27:401-7.
25. Goldberg SN, Girnan GD, Lukyanov AN, et al. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology 2002;222:797-804.
26. He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998;95:2509-14.
27. Anderson RD, Haskell RE, Xia H, et al. A simple method for the rapid generation of recombinant adenovirus vectors. Gene Ther 2000;7:1034-8.
28. Thompson SW, Hunt RD. Selected histochemical and histopathological methods. Springfield (IL): Charles C. Thomas; 1996.
29. Bhushan KR, Tanaka E, Frangioni JV. Synthesis of conjugatable bisphosphonates for molecular imaging of large animals. Angew Chem Int Ed Engl 2007;46:7969-71.
30. Nakayama A, del Monte F, Hajjar RJ, Frangioni JV. Functional near-infrared fluorescence imaging for cardiac surgery and targeted gene therapy. Mol Imaging 2002;1:365-77.
31. Lenkinski RE, Ahmed M, Zaheer A, et al. Near-infrared fluorescence imaging of microcalcification in an animal model of breast cancer. Acad Radiol 2003;10:1159-64.
32. Zaheer A, Lenkinski RE, Mahmood A, et al. In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol 2001;19:1148-54.
33. Zaheer A, Murshed M, De Grand AM, et al. Optical imaging of hydroxyapatite in the calcified vasculature of transgenic animals. Arterioscler Thromb Vasc Biol 2006;26:1132-6.
34. Alarmo EL, Kuukasjarvi T, Karhu R, Kallioniemi A. A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7. Breast Cancer Res Treat 2006;103:239-46.
35. Sato K, Urist MR. Induced regeneration of calvaria by bone morphogenetic protein (BMP) in dogs. Clin Orthop Relat Res 1985;197:301-11.
36. Hoodless PA, Haerry T, Abdollah S, et al. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 1996;85:489-500.
37. Liu X, Yue J, Frey RS, et al. Transforming growth factor beta signaling through Smad1 in human breast cancer cells. Cancer Res 1998;58:4752-7.
38. Wang Q, Wei X, Zhu T, et al. BMP-2 activates Smad6 gene transcription through bone-specific transcription factor Runx2. J Biol Chem 2007;282:10742-8.
39. Kimura N, Matsuo R, Shibuya H, et al. BMP2-induced apoptosis is mediated by activation of the TAKl-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem 2000;275:17647-52.
40. Raida M, Clement JH, Leek RD, et al. Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol 2005; 131:741-50.
41. Ghosh-Choudhury N, Mandal CC, Ghosh Choudhury G. Statin-induced Ras activation integrates PI 3 kinase signal to AKT and MAPK for BMP-2 expression in osteoblast differentiation. J Biol Chem 2006;282:4983-93.
42. Ishihara A, Shields KM, Litsky AS, et al. Osteogenic gene regulation and relative acceleration of healing by adenoviral-mediated transfer of human BMP-2 or -6 in equine osteotomy and ostectomy models. J Orthop Res 2008;26:764-71.
43. Pouliot F, Blais A, Labrie C. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. Cancer Res 2003;63:277-81.
44. Arnold SF, Tims E, McGrath BE. Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2. Cytokine 1999;11:1031-7.